Forbes September 9, 2024
Michel van Harten

Dr. Michel van Harten, CEO of myTomorrows, helping patients discover and access treatments.

They say, “Knowledge is power.” But does this platitude hold true when so much content online can be classified as misinformation? Where do we draw the line between empowered and misled?

Credible information is increasingly harder to find given the sheer volume of online content, the abundance of misinformation on social media and the inevitable inaccuracies of unproven early-stage generative AI. And in the realm of healthcare, this can be especially dangerous. The consequences of medical misinformation—or even information that may be accurate but isn’t personally relevant—can be dire not only for patients but also for healthcare professionals (HCPs) and the wider BioPharma industry.

Although medical misinformation...

Today's Sponsors

Venturous
ZeOmega

Today's Sponsor

Venturous

 
Topics: Patient / Consumer, Provider, Social Media, Technology
AI-enabled clinical data abstraction: a nurse’s perspective
HCA’s 2025 revenue surpassed $75B: 10 things to know
Cardiology’s outpatient shift: a recent history
‘An exciting time for osteopathic medicine’ — growth in numbers, influence, financial effect
CMS Signals MA Payment Slowdown as Provider Frustration With The Plans Continue to Mount

Share Article